We provide you with 20 years of free, institutional-grade data for LCTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LCTX. Explore the full financial landscape of LCTX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about LCTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lineage Cell Therapeutics, Inc(NYSE MKT:LCTX) 
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...
Website: http://www.lineagecell.com
Full Time Employees: 50
CEO: Brian M. Culley
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends